Oncology & Cancer

CVD risk up with androgen deprivation Tx in prostate cancer

(HealthDay)—For men with prostate cancer (PCa), the risk for incident cardiovascular disease (CVD) is increased with androgen deprivation therapy (ADT), according to a study published online March 2 in the Journal of Clinical ...

Oncology & Cancer

Can statins help improve prostate cancer survival?

(HealthDay)—Cholesterol-lowering statin drugs may slow down prostate cancer in men who are also taking medication to reduce their levels of male hormones, according to new research.

Medications

Sipuleucel-T in prostate cancer: Added benefit is not proven

Sipuleucel-T (trade name Provenge) has been approved since September 2014 for men with metastatic prostate cancer who have few or no symptoms and do not yet require chemotherapy. The German Institute for Quality and Efficiency ...

Diseases, Conditions, Syndromes

Study examines use of drugs to strengthen bones for men receiving ADT

Although some guidelines recommend use of bisphosphonates (a class of drugs used to strengthen bone) for men on androgen deprivation therapy, an analysis finds that prescriptions for these drugs remains low, even for those ...

page 8 from 11